Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial

Browse by...

Deposit

Highlights

More informations

Title		Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial
Authors		Iglesias, Juan Fernando Muller, Olivier Losdat, Sylvain Roffi, Marco Kurz, David J Weilenmann, Daniel Kaiser, Christoph Valgimigli, Marco Windecker, Stephan Pilgrim, Thomas show all authors [1 - 10]
Published in		JACC. Cardiovascular interventions. 2020, vol. 13, no. 19, p. 2314-2316
Keywords		Absorbable Implants — Coronary Artery Disease / therapy — Drug-Eluting Stents — Everolimus — Humans — Percutaneous Coronary Intervention — Prosthesis Design — Sirolimus — Treatment Outcome
Identifiers		DOI: 10.1016/j.jcin.2020.07.038 PMID: 33032722
Full text		Article (Published version) (181 Kb) - Free access
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine
Citation (ISO format)		IGLESIAS, Juan Fernando et al. Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial. In: JACC. Cardiovascular interventions, 2020, vol. 13, n° 19, p. 2314-2316. doi: 10.1016/j.jcin.2020.07.038 https://archive-ouverte.unige.ch/unige:161613